Effects of Diet Manipulation on Women in the Curves Program (Curves2)
Effects of a Carbohydrate Restricted, High Protein, High Fat Diet on Weight Loss and Health Outcomes in Women Participating in the Curves Fitness and Weight Loss Program
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- The participant is an apparently healthy female
- The participant is between the ages of 18 and 60
Exclusion Criteria:
- The participant is pregnant or nursing, or plans to become pregnant during the next 12 months or has been pregnant in the past 12 months
- The participant has uncontrolled metabolic disorder including known electrolyte abnormalities; heart disease, arrhythmias, diabetes, thyroid disease, or hypogonadism; a history of hypertension, hepatorenal, musculoskeletal, autoimmune, or neurological disease
- The participant is currently taking thyroid, hyperlipidemic, hypoglycemic, anti-hypertensive, or androgenic medications
- The participant has taken ergogenic levels of nutritional supplements that may affect muscle mass (e.g., creatine, HMB), anabolic/catabolic hormone levels (androstenedione, DHEA, etc.) or weight loss (e.g., ephedra, thermogenics, etc.) within the past three months
- The participant is willing to participate in a regular moderate exercise program
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Placebo Comparator: Control
(no diet or exercise intervention)
|
|
|
Experimental: American Heart Association
(AHA: 55% carbohydrate, 15% protein, 30% fat - diet plus exercise)
|
|
|
Active Comparator: Curves Complete - I
(CC - I: 30% carbohydrate, 45% protein, 25% fat - diet plus exercise)
|
|
|
Active Comparator: Curves Complete - II
(CC - II: 20% carbohydrate, 45% protein, 35% fat - diet plus exercise)
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Effects of the Curves program on physical activity patterns
Time Frame: 24 weeks
|
24 weeks
|
|
Effects of the Curves program on body weight
Time Frame: 24 weeks
|
24 weeks
|
|
Effects of the Curves program on the hip/waist ratio
Time Frame: 24 weeks
|
24 weeks
|
|
Effects of the Curves program on Resting Energy Expenditure (REE)
Time Frame: 24 weeks
|
24 weeks
|
|
Effects of the Curves program on Blood Pressure (BP)
Time Frame: 24 weeks
|
24 weeks
|
|
Effects of the Curves program on Heart Rate (HR)
Time Frame: 24 weeks
|
24 weeks
|
|
Effects of the Curves program on body composition (DXA)
Time Frame: 24 weeks
|
24 weeks
|
|
Effects of the Curves program on Bioelectrical Impedance Analysis (BIA)
Time Frame: 24 weeks
|
24 weeks
|
|
Effects of the Curves program on a chemistry-15 blood panel
Time Frame: 24 weeks
|
24 weeks
|
|
Effects of the Curves program on a cell blood count (CBC) blood panel
Time Frame: 24 weeks
|
24 weeks
|
|
Effects of the Curves program on lipid panels
Time Frame: 24 weeks
|
24 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Effects of the Curves program on maximal cardiopulmonary capacity
Time Frame: 24 weeks
|
24 weeks
|
|
Effects of the Curves program on muscular strength through a 1 repetition maximum (1 RM) test
Time Frame: 24 weeks
|
24 weeks
|
|
Effects of the Curves program on muscular endurance through a maximal repetition test
Time Frame: 24 weeks
|
24 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Richard B Kreider, PhD, Texas A&M University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- IRB2013-0495FX
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.